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  Alpha-fetoprotein (AFP)-producing gastric carcinoma (APGC) is well known to have a poor 
prognosis and high incidence of lymph node and liver metastases compared to non-producing 
carcinoma.  Although the reason why APGC frequently metastasizes to the liver is not well 
known.  We hypothesizes that angiogenesis is one of the important reasons for frequent liver 
metastases from APGC.  In order to clarify this hypothesis, we examined the vessel density and 
vascular endothelial growth factor (VEGF) expression in APGC.  Furthermore, we studied the 
effects of anti-AFP antibody for angiogenesis using APGC xenotransplanted mouse model. 
  Archival specimens of APGC (n=25) and non-APGC (n=68) were studied.  Expressions of 
vessel density and VEGF were significantly higher in APGC than those in non-APGC (p<0.001).  
Immunohistochemical analysis of patients with gastric cancer shows that expression of VEGF 
and factor VIII are significantly higher in APGC than non-APGC.  There is correlation among 
the AFP expression, the vessel density and the VEGF expression in APGC (p<0.001). 
  Next, we studied the effects of anti-AFP antibody on APGC xenotransplanted in nude mice.  
There is significant inhibition of tumor growth in the treatment groups compared to the control 
groups in two APGC lines (p<0.01).  But, there is no difference in non-APGC cell line.  
Moreover, vessel densities of the treatment groups were significantly lower than those of the 
control groups in these two lines.  These findings thus suggest that the biological behavior of 
APGC is angiogenesis-dependent.  Down regulation of angiogenesis by anti-AFP antibody 
suggest that AFP itself may upregulate the angiogenesis, and the treatment by antibody could 
have anti-angiogenic effects, inhibiting metastasis, especially liver metastasis in APGC.  
 
   
